. Characteristics of DLBCL cell lines. Characteristics of the DLBCL cell lines and their cell of origin (COO), IC50 value for AZD1775, TP53 mutation status and cytogenetic profile (DSMZ/ATCC).
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Human flat-moded hypertriploid karyotype; 72-77 < 3n > XXYY, +1, +9, -10, +13, +14, -17, +19, +20, +22, der(1)t(1;17)(p13;q12)x2, der(4)t(4;18)(q31;q21)x2, del(6)(q13)x2, der(6)t(6;6)(p24;q12), der(7)t(6;7)(p24;p22), der (14) 
Cell line AZD1775 (µM) BIM (µM) NOXA (µM) HRK (µM) BAD (µM)
OCI-LY3 0.5 0.1 10 10 0.1 U-2932 0.5 0.1 10 10 0.1 SUDHL-2 0.5 0.1 10 10 10 SUDHL-4 1 0.1 10 10 0.1 SUDHL-5 0.5 0,1 10 10 10 SUDHL-6 1 0.03 10 10 1 SUDHL-10 0.25 0.1 10 10 10 SC-1 1 0.3 10 10 0.1 Figure S8 . DLBCL cells treated with AZD1775. Representative DLBCL cell line U-2932 was treated with 0.5 µM AZD1775 for 24 h. Protein analysis was performed for WEE1, phospho-CDC2 (Tyr15) for WEE1 activity, yH2AX and cleaved PARP.
